Journal
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY
Volume 9, Issue 4, Pages 298-304Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ACI.0b013e32832d5311
Keywords
basophil activation test; beta-lactams; drug allergy; in-vitro diagnosis; muscle relaxants; NSAIDs
Categories
Funding
- Spanish Research Network on Adverse Reactions to Allergens and Drugs [RD07/0064]
Ask authors/readers for more resources
Purpose of review The aim of this study was to confirm the applicability of the basophil activation test (BAT), in the in-vitro diagnosis of drug allergy reactions. Recent findings The results obtained in terms of sensitivity and specificity with BAT are encouraging and in significant number of cases can establish the diagnosis. Summary BAT sensitivity in beta-lactam allergy was 50%, and specificity ranged from 89 to 97%. There are several studies to validate the BAT in allergy to muscle relaxants showing a sensitivity ranging from 54 to 64% with a specificity of 100 and 93%. The sensitivity of a test for evaluating immediate allergic reactions to drugs may decrease over time. To date, the BAT is the only in-vitro diagnostic method that has been validated for the diagnosis of both IgE-mediated and hypersensitivity reactions to NSAIDs. With respect to other drugs, they are nonetheless interesting as they include the evaluation of allergy to drugs that cannot be studied by other in-vitro techniques. All these data suggest that although a full validation of the test is required, BAT is a potential diagnostic method for evaluating immediate allergic reactions to drugs and NSAID hypersensitivity reactions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available